These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36513119)

  • 1. High-dose vasoactive agents in aeromedical retrievals for septic shock: A role for vasopressin?
    Aston B; Allen K; Hamilton A
    Emerg Med Australas; 2023 Apr; 35(2):344-346. PubMed ID: 36513119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
    Saad AF; Maybauer MO
    J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vasopressin in vasodilatory septic shock.
    Obritsch MD; Bestul DJ; Jung R; Fish DN; MacLaren R
    Pharmacotherapy; 2004 Aug; 24(8):1050-63. PubMed ID: 15338853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin for vasopressor-dependent septic shock.
    Szumita PM; Enfanto CM; Greenwood B; Wechsler ME
    Am J Health Syst Pharm; 2005 Sep; 62(18):1931-6. PubMed ID: 16141113
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of vasopressin in the management of septic shock.
    Mutlu GM; Factor P
    Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Carr AC; Shaw GM; Fowler AA; Natarajan R
    Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Vasopressin Use for Adults with Septic Shock.
    Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
    Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 15. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
    Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J; Cai H; Zheng X
    BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vasopressin in distributive shock : Brief summary of the guidelines of the Canadian Critical Care Society published in December 2019].
    Bayerl S; Wöhrle T; Kilger E
    Anaesthesist; 2020 Mar; 69(3):159-161. PubMed ID: 32055884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
    Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
    Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications of vasopressin in the management of septic shock].
    Delmas A; Leone M; Rousseau S; Albanèse J; Martin C
    Ann Fr Anesth Reanim; 2003 Jul; 22(7):600-8. PubMed ID: 12946492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.